Search results
Results from the Tech24 Deals Content Network
Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and also by private entities. In September 2021, President Joe Biden announced that the federal government would take steps to mandate COVID-19 vaccination for certain entities under the authority of ...
A universal vaccine would provide protection against coronavirus strains that have caused disease in humans, such as SARS-CoV-2(including all its variants), while also providing protection against future coronavirus strains. Such a vaccine has been proposed to preventor mitigate future coronavirus epidemicsand pandemics. [1][2][3][4][5][6][7][8]
New York City Subway passengers on March 9, when there were 16 confirmed cases of COVID-19 in New York City, with NYC Transit Interim President Sarah Feinberg on the right. On March 3, New York Governor Andrew Cuomo announced that the first recorded case of person-to-person spread in New York State had been confirmed via a New Rochelle man who ...
Two years ago, Pfizer was the envy of the pharmaceutical world, with more than $100 billion in annual sales from its COVID-19 vaccine and antiviral Paxlovid. Today, CEO Albert Bourla is trying to ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [ 7] and mass vaccinations began four days later. The Moderna ...
The first case of COVID-19 in the U.S. state of New York during the pandemic was confirmed on March 1, 2020, [2] and the state quickly became an epicenter of the pandemic, with a record 12,274 new cases reported on April 4 and approximately 29,000 more deaths reported for the month of April than the same month in 2019. [7]
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [ 2][ 32] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [ 44][ 45] It is authorized for ...
A number of Covid variants are in circulation in the U.S. including HV.1 and BA.2.86. Experts say the variants are not a cause for concern, though Covid is causing 15,000 hospitalizations a week.